arginine has been researched along with butaclamol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Caron, MG; Charpentier, S; Jarvie, KR; Severynse, DM; Tiberi, M | 1 |
2 other study(ies) available for arginine and butaclamol
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Silencing of the constitutive activity of the dopamine D1B receptor. Reciprocal mutations between D1 receptor subtypes delineate residues underlying activation properties.
Topics: Adenylyl Cyclases; Arginine; Benzazepines; Binding, Competitive; Butaclamol; Cyclic AMP; Dopamine; Dose-Response Relationship, Drug; Humans; Isoleucine; Models, Molecular; Phenylalanine; Protein Conformation; Receptors, Dopamine D1; Receptors, Dopamine D5; Structure-Activity Relationship | 1996 |